CORT returns by year
Corcept Therapeutics Incorporated has returned +10.6% annually (CAGR) since 2005. Calendar-year, monthly and weekly total returns for Corcept Therapeutics Incorporated (CORT) below, through August 13, 2026 — the most recent year is year-to-date.
Corcept Therapeutics Incorporated returns by year (2005–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return).
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $34.80 | $110.65 | +0.0% | +218.0% | |
| 2025 | $50.39 | $34.80 | +0.0% | -30.9% | |
| 2024 | $32.48 | $50.39 | +0.0% | +55.1% | |
| 2023 | $20.31 | $32.48 | +0.0% | +59.9% | |
| 2022 | $19.80 | $20.31 | +0.0% | +2.6% | |
| 2021 | $26.16 | $19.80 | +0.0% | -24.3% | |
| 2020 | $12.10 | $26.16 | +0.0% | +116.2% | |
| 2019 | $13.36 | $12.10 | +0.0% | -9.4% | |
| 2018 | $18.06 | $13.36 | +0.0% | -26.0% | |
| 2017 | $7.26 | $18.06 | +0.0% | +148.8% | |
| 2016 | $4.98 | $7.26 | +0.0% | +45.8% | |
| 2015 | $3.00 | $4.98 | +0.0% | +66.0% |
Total return by period
Methodology#
Returns are total returns (dividends reinvested), computed from CORT's split- and dividend-adjusted closes. The bar chart switches between annual and monthly periods. Annualized return is the compound annual growth rate over the full period. The current year is year-to-date. See also the periodic table of returns. Past performance does not predict future returns; not investment advice.
See also: S&P 500 · Nasdaq-100 · Dow Jones · Russell 2000 · US Bond Market · Gold · Silver · Bitcoin · Ethereum
FAQ#
- What is Corcept Therapeutics Incorporated's average annual return?
- Since 2005, Corcept Therapeutics Incorporated (CORT) has returned about 10.6% a year (the compound annual growth rate) and an average calendar-year return of 30.5%.
- What were Corcept Therapeutics Incorporated's best and worst years?
- Over 2005–2026, the best year was 2009 (+172.5%) and the worst was 2008 (-67.0%).
- How often is Corcept Therapeutics Incorporated up in a year?
- 11 of the 21 full years since 2005 were positive — about 52% of the time.